ABSTRACT
VIRUS samples from people in the UK with severe respiratory infections, such as flu and RSV, will be routinely tested by DNA sequencing. "Other than a small amount of genome sequencing in flu cases, there really isn't any routine genomic surveillance of these other viruses", says Harrison. [Extracted from the article] Copyright of New Scientist is the property of New Scientist Ltd. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)
ABSTRACT
Global vaccine inequality, waning immunity and evolving variants mean jabs are still needed, but new ones are unlikely in 2023, says Michael Le Page.
ABSTRACT
Nasal vaccines may stem transmission, while universal ones could target proteins in every SARS-CoV-2 variant and even other coronaviruses, reports Michael Le Page.
ABSTRACT
A study has found that people who catch the coronavirus two or three times go on to have higher rates of everything from heart disease to kidney disorders, reports Michael Le Page.
ABSTRACT
Cases are rising worldwide, leaving some people anxious that the virus could evolve into a pandemic alongside covid-19. Michael Le Page addresses monkeypox's risks.
ABSTRACT
“Deltacron” variants of coronavirus pose a threat, finds Michael Le Page, but they aren't the worst-case scenario
ABSTRACT
Cases of covid-19 are climbing sharply again, and China in particular faces a potential disaster if it fails to contain its biggest outbreak since 2020, reports Michael Le Page.
ABSTRACT
Covid-19 cases are soaring among largely unvaccinated older groups and hospitals are overwhelmed, reports Michael Le Page
ABSTRACT
The BA.2 variant of the coronavirus is spreading fast, but it shouldn't cause another worldwide wave, says Michael Le Page.
ABSTRACT
Studies are beginning to shed light on why omicron behaves so differently to other coronavirus variants, reports Michael Le Page.
ABSTRACT
Expect more viral evolution but reduced mortality, and some continuing restrictions, report Helen Thomson, Clare Wilson and Michael Le Page
ABSTRACT
We failed to prevent the emergence of omicron, but there are things we can do to halt the evolution of more variants, reports Michael Le Page.
ABSTRACT
More SARS-CoV-2 variants are inevitable. Michael Le Page reveals what to expect from them
ABSTRACT
An offshoot of the delta coronavirus variant, known as AY.4.2, appears to be more transmissible, but not more dangerous, says Michael Le Page.